TABLE 3

Patient-Related Variables Associated with Significantly Lower Cardiac 18F-FDG Uptake (Univariate Analysis)

VariablePatients with or without variableSUVmean in patients with variable*SUVmean in patients without variable*P
Diabetes70/4062.53 ± 1.773.30 ± 2.410.007
Glucose (>150 mg/dL)43/4532.04 ± 2.383.28 ± 1.280.001
Oral antidiabetic treatment53/4512.50 ± 2.183.24 ± 2.310.001
Bezafibrate treatment (lipid-lowering drug)11/4931.65 ± 1.473.19 ± 2.320.001
Levothyroxine treatment (thyroid replacement drug)40/4642.42 ± 1.783.23 ± 2.350.028
  • * Mean ± SD.